Deignan Charles A. 4
4 · Clearside Biomedical, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-04+187,500→ 187,500 totalExercise: $1.48Exp: 2033-01-04→ Common Stock (187,500 underlying)
Footnotes (1)
- [F1]One-fourth of the shares underlying this option vest on January 4, 2024 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.